Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18edbc85f7924a07dfe1966c49ca109b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
filingDate |
1987-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f031a28fdc284c5155fdc525ebafb37 |
publicationDate |
1988-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
DE-3710921-A1 |
titleOfInvention |
USE OF PAF ACETHER BONDING INHIBITING SUBSTANCES |
abstract |
Substances which inhibit the PAF-acether binding sites on cells are used for the treatment of disorders caused by lowering of the endothelial cell barrier. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-1000264-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5852052-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0312913-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9001927-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5002965-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0604830-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0312913-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0459432-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5895785-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1003455-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2622448-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0604830-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3735525-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2622584-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9001927-A3 |
priorityDate |
1986-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |